Go Deep
Protagonist Therapeutics, Inc.
Protagonist Therapeutics, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 15,885 | 139.5 | 11.05 | 0.01 | 13,882.65 |
| Oct 2026 | 15,796 | 140.7 | 11.14 | 0.01 | 13,870.89 |
| Oct 2026 | 16,253 | 134.5 | 10.65 | 0.01 | 13,188.92 |
| Oct 2026 | 16,408 | 132.3 | 10.48 | 0.01 | 12,939.44 |
| Oct 2026 | 16,387 | 135.2 | 10.50 | 0.01 | 12,966.93 |
| Oct 2026 | 16,939 | 125.0 | 9.90 | 0.01 | 12,194.55 |
| Oct 2026 | 16,538 | 130.5 | 10.34 | 0.01 | 12,747.12 |
| Oct 2026 | 16,288 | 134.0 | 10.61 | 0.01 | 13,083.71 |
| Oct 2026 | 16,281 | 134.1 | 10.62 | 0.01 | 13,059.91 |
| Oct 2026 | 16,179 | 135.5 | 10.73 | 0.01 | 13,170.35 |
Protagonist Therapeutics, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 213,475,000.0 | 56,368,000.0 | 7,437,000.0 | 4,712,000.0 |
| Net Profit | 162,849,000.0 | 3,783,000.0 | -44,384,000.0 | -39,339,000.0 |
| EPS | 2.5 | 0.1 | -0.7 | -0.6 |
Protagonist Therapeutics, Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 46,016,000.0 | 434,433,000.0 | 60,000,000.0 | 26,581,000.0 | — |
| Net Profit | -130,149,000.0 | 275,188,000.0 | -78,955,000.0 | -127,393,000.0 | — |
| EPS | -2.0 | 4.5 | -1.4 | -2.6 | — |
Protagonist Therapeutics, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 668,188,000.0 | 744,725,000.0 | 357,951,000.0 | 247,928,000.0 | — |
| Total Liabilities | 53,481,000.0 | 69,430,000.0 | 21,274,000.0 | 32,320,000.0 | — |
| Total Equity | 614,707,000.0 | 675,295,000.0 | 336,677,000.0 | 215,608,000.0 | — |
Owes vs Owns
Protagonist Therapeutics, Inc. owed $0.05 for every $1 it owned in Jun 2026, down from $0.13 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.05× | 0.08× | 0.09× | 0.06× | 0.13× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Protagonist Therapeutics, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 84.9%Receivables 0.7%Fixed assets (tangible) 1.7%Long-term investments 11.8%Other assets 0.9%
How it's funded — Dec 2025
Long-term debt 1.2%Payables 0.8%Other liabilities 5.7%Shareholders' equity 92.0%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 567.4 | 418.9 | 341.6 | 237.4 |
| Receivables | 4.5 | 168.5 | 10.3 | 0.1 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 11.7 | 12.6 | 2.1 | 4.6 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 78.6 | 140.3 | 0.0 | 0.0 |
| Other assets | 6.0 | 4.5 | 3.9 | 5.9 |
| Liabilities & equity | ||||
| Short-term debt | 2.3 | 0.5 | 1.1 | 2.5 |
| Long-term debt | 8.0 | 10.4 | 0.0 | 1.1 |
| Payables | 5.3 | 1.6 | 0.8 | 3.6 |
| Other liabilities | 37.8 | 56.9 | 19.4 | 25.0 |
| Shareholders' equity | 614.7 | 675.3 | 336.7 | 215.6 |
| Net tangible assets | 614.7 | 675.3 | 336.7 | 215.6 |
Protagonist Therapeutics, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 57,671,000.0 | 184,152,000.0 | -70,236,000.0 | -108,137,000.0 | — |
| Investing Activities | -49,332,000.0 | -299,483,000.0 | -39,258,000.0 | 91,468,000.0 | — |
| Financing Activities | 22,864,000.0 | 25,853,000.0 | 170,477,000.0 | 18,838,000.0 | — |